Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. They accelerate Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology.Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies. They attract, develop, and retain the top scientific, entrepreneurial, and managerial talent in the world.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 19, 2022
Tessera Therapeutics
|
Series C | $300M | Biopharma | — |
Nov 18, 2021
Generate Biomedicines
|
Series B | $370M | Biotechnology | — |
Jan 12, 2021
Tessera Therapeutics
|
Series B | $230M | Biopharma | — |
Sep 10, 2020
Generate Biomedicines
|
Series Unknown | $50M | Biotechnology | Yes |
Jul 11, 2017
Evelo Biosciences
|
Series B | $50M | Biotechnology | Yes |